ANC

Dec 31 2024HEALTH

Tislelizumab and Chemo: A Cost-Effective Pair for Advanced Stomach Cancer in China

Imagine you're a healthcare provider in China, trying to figure out the best treatment for advanced stomach cancer. A recent study, RATIONALE-305, found that combining a drug called tislelizumab with chemo works better than chemo alone. Now, researchers wanted to know if this combo is worth the extr

reading time less than a minute
Dec 31 2024SCIENCE

Boosting Cassava's Drought Tolerance: A Genomic Approach

Selecting cassava plants that can withstand drought is tough because it depends on many factors. This study tried to find the best way to pick drought-tolerant cassava clones using genomic selection. They used different methods like Best Linear Unbiased Predictions (BLUPs), Genomic Estimated Breedin

reading time less than a minute
Dec 31 2024HEALTH

Immune Cell Shifts: A Look at PD-1 Inhibitors in Melanoma and Lung Cancer

Imagine you're battling advanced malignant melanoma or non-small cell lung cancer. Doctors might use immune checkpoint inhibitors, like those targeting PD-1, to help your body fight the disease. But here’s the thing: only about 20-40% of patients actually see real benefits. So, scientists set out to

reading time less than a minute
Dec 31 2024SPORTS

Who Stood Out: Giants’ Performance Against Colts

The New York Giants put on a great show against the Indianapolis Colts, scoring a whopping 45 points. While fans might have mixed feelings about this due to draft positioning, it's still interesting to see who shone and who didn't. Pro Football Focus (PFF) has some insights. Firstly, the Giants’ off

reading time less than a minute
Dec 31 2024HEALTH

How Medicine Marched Forward in 2024: Surprising Twists and Turns

2024 has been a wild ride for medical advancements! Imagine shrinking cancer tumors with pills or genetically engineered superhero cells? Or replacing a heart valve without opening up the chest? These weren't possible two decades ago. But what made 2024 special? Let's dive in! First, GLP-1 drugs, o

reading time less than a minute
Dec 31 2024POLITICS

Woke or Not: Where Do We Stand?

Are we truly done with the era of "wokeness"? Some people think so, especially after certain election results. They believe we've moved past the days of endless debates about topics like whether women can have penises, or if being fat is healthy. But is it really that simple? Many institutions, fro

reading time less than a minute
Dec 31 2024POLITICS

How Marc Elias's Legal Move Boosted Trump

In March, a significant change in campaign finance rules happened, thanks to a petition from Democratic lawyer Marc Elias. The Federal Election Commission (FEC) allowed political campaigns and outside political action committees (PACs) to work together on canvassing efforts to get out the vote. This

reading time less than a minute
Dec 31 2024SCIENCE

Discovering Methotrexate's Role in Lung Cancer Treatment

MicroRNAs, or miRNAs, are tiny molecules that can greatly influence how cancer cells grow. Out of all these miRNAs, miR-20b is particularly interesting because it's often out of balance in lung cancer. Scientists used a special computer program to search for small molecules that could tame miR-20b.

reading time less than a minute
Dec 31 2024TECHNOLOGY

How GPT-4 Can Assist in Coding Better Than Most Humans

Imagine you're trying to write a piece of code. You could do it yourself, or you could let GPT-4, one of the top large language models (LLMs), give it a shot. Researchers tested seven of these models with different coding tasks, languages, and difficulties. GPT-4 came out on top, especially when giv

reading time less than a minute
Dec 31 2024SPORTS

Who's Doing Well at Man United Since Amorim's Arrival?

Manchester United legend Gary Neville has highlighted a small group of players who he thinks have been doing okay since Ruben Amorim took over as manager. Speaking during a recent match against Newcastle United, Neville singled out Amad Diallo, Diogo Dalot, and Noussair Mazraoui as the only three pl

reading time less than a minute